Over a million children still die each year from diseases that are largely preventable with clean water, sanitation, and vaccines — yet the pace of improvement is slowing precisely where it matters most. This landmark analysis from the Global Burden of Disease Study 2023 offers the most comprehensive reckoning to date of enteric infectious disease mortality, revealing a mixed picture: dramatic historical gains now facing structural headwinds.
Drawing on data across 204 countries and territories from 1990 to 2023, the GBD 2023 team quantified incidence, mortality, and disability-adjusted life-years (DALYs) for the full spectrum of enteric infectious diseases — diarrhoeal diseases, enteric fever (typhoid and paratyphoid), invasive non-typhoidal Salmonella infections, and other intestinal infections — along with 15 specific diarrhoeal aetiologies. Using DisMod-MR 2.1, a Bayesian meta-regression framework integrating systematic reviews, population surveys, and hospital data, the analysis found mortality reductions of roughly 60% since 1990 in children under five. However, progress toward the GAPPD target of fewer than 20 deaths per 100,000 children under five by 2025 remains uneven, with sub-Saharan African and South Asian regions lagging critically behind.
This study carries particular weight because it benchmarks the entire global trajectory against an actionable 2025 policy milestone. The 60% reduction in child mortality from enteric diseases over three decades reflects genuine public health achievements — oral rehydration therapy scale-up, rotavirus vaccination, and sanitation investments — but this analysis makes clear those gains are not self-sustaining. Rotavirus remains among the leading diarrhoeal killers despite vaccine availability, pointing to implementation gaps rather than scientific ones. The inclusion of invasive non-typhoidal Salmonella as a discrete tracked pathogen also signals growing recognition of this underappreciated bacteremic threat, particularly in malnourished children. From a longevity and healthspan perspective, early-life enteric disease burden carries long-term consequences including stunting and impaired neurodevelopment. The study's Bayesian modeling approach adds methodological rigor, though estimates in data-sparse regions carry uncertainty. The central policy message is clear: the tools exist, but deployment is stalling in the places of greatest need.